BILAT USA 2.0 EU-U.S. Innovation Conference “How to integrate the innovation dimension in the EU-US S&T Agreement?”
ThThe BILAT USA 2.0 project (FP7) is organising the EU-US Innovation Conference on 14 – 15 January in Brussels.
The conference will focus on the question of “How to strengthen the innovation dimension in the future EU-U.S. Science and Technology (S&T) Agreement?”.
Representatives of DG Research and Innovation, representatives of ministries, American counterparts as well as experts from industry will present best-practices of successful innovation cooperation between the EU and the USA, with the aim to gain input and concrete suggestions on how to improve framework conditions for enhanced innovation cooperation.
There will further be a pre-conference workshop entitled “Towards enhanced EU-US innovation collaboration through policy measures” in the morning before the innovation conference.
For further information please contact Heino NAU, DG RTD
BILAT USA 2.0 EU Info Tour took place in Brussels, Oslo and Berlin
Three parallel info sessions on U.S. funding opportunities for European researchers were organised by the EU-funded BILAT USA 2.0 project (FP7) in Brussels, Oslo and Berlin, on 27-31 October 2014.
The information sessions on open U.S. funding programmes put a special focus on the US National Institutes of Health (NIH) as well as the US National Science Foundation (NSF). On the one hand, the events were designed to show open funding sources and on the other hand to debate on the administrative challenges related to U.S. federal research grants application and management.
The workshops were attended by participants coming from across Europe: UK, Belgium, Germany, Norway, Spain, Italy, Poland and Czech Republic. Several researchers from high-level European and international research organisations and research managers were actively involved in the discussions. Key questions evolved around priority issues that EU researchers should consider, in order to be funded and how to manage the funds successfully. Questions such as “What is different, if we compare it with the EU funds?” were clarified by EU and US experts.
Vivian Holmes, Director of Sponsored Research Operations at the Broad Institute of MIT and Harvard (USA) as well as Patricia Hawk, Director of the Office of Sponsored Programs at Oregon State University (USA) provided the audience with detailed insights into the U.S. funding environment as well as gave hints and practical tips for U.S. grants management.
In addition to the broad U.S. perspective, two European experts were invited to talk about their “best-practices” with U.S. funding: Eva Björndal, Director for Post-Contract Office at Karolinska Institutet (Sweden) and Regina Notz, Senior Manager of EU Grants Access (Switzerland) presented their experiences, challenges and opportunities deriving from U.S. grants, including aspects such as compliance issues, different utilisation of terminology, places to find relevant information etc.
The BILAT USA 2.0 events have reached a large audience, showing the significant demand for detailed and practical information on alternative funding sources to support research and innovation.
More information: BILAT USA 2.0.
For further information please contact Heino NAU, DG RTD
The EU-US "Agreement for Scientific and Technological Cooperation" was originally signed in 1998 and renewed in 2004. It was renewed for a second time in 2009 for a period ending in October 2013.
As of end 2012, there were 287 US instances of participation with signed grant agreements for cooperation projects under the 7th Framework Programme for Research and Development (FP7), with a total EU contribution to US participants of about €51 million. Among the Third Countries (with specific FP7 status), among the total number of signed grant agreements, the US ranks 2nd in terms of FP7 participations, as well as 2nd in terms of FP7 budget share, after the Russian Federation. Project participants from the US (as an industrialised country) do not automatically receive funding from FP7, except under the Health theme of the "Cooperation" Programme.
US participation in FP7 is the most prominent in the themes of Health; Information and Communications Technologies (ICT); Food, Agriculture & Fisheries and Biotechnology (FAB); and Nanosciences, Nanotechnologies, Materials and Production Technologies (NMP). 75 % of all Marie Curie International Outgoing Fellowship holders go to the US, while American researchers account for 14% of Marie Curie International Incoming Fellowships.
- In June 2011, Commissioner Geoghegan-Quinn signed an Implementing Arrangement (under the S&T agreement) for the renewal of the EC-US Task Force on Biotechnology Research. The US Secretary of Agriculture, Tom Vilsack signed for the US side.
- On 29 November 2011 the EU-US Summit created a High Level Working Group on Jobs and Growth and endorsed the work of the Transatlantic Economic Council (TEC). In the margins of the TEC meeting, the Commission's Joint Research Centre (JRC) and the US Department of Energy (DOE) signed a Letter of Intent on the establishment of two e-vehicle–smart grid interoperability centres in the US (Chicago) and in the EU (Ispra).
- On 20 January 2011 the first event of the Destination Europe initiative took place in Boston, supported by Commissioner Geoghegan-Quinn.
- On 21 May 2012 Commissioner Tajani signed a Letter of Intent on space cooperation with Robert Hormats, Under Secretary for Economic Growth, Energy and Environment, Department of State.
- On 31 May 2012 Director General Ristori of JRC signed an Implementing Arrangement with NOAA Administrator, Jane Lubchenco.
- On 13 July 2012 during the ESOF conference in Dublin, an Implementing Arrangement between ERC and the National Science Foundation (NSF) was signed by Commissioner Geoghegan-Quinn and Director Subra Suresh of NSF.
FP7 funded projects and activities to facilitate EU-US Cooperation:
The BILAT-USA 2 project (2012-2015) is a bilateral coordination activity to enhance and develop science, technology and innovation (STI) partnerships between the European Union and the United States of America. It has three main goals: (1) support the policy dialogue within the framework of the EU-US STI cooperation agreement; (2) enhance the cooperation between research and innovation actors on both sides and spread information on funding possibilities through workshops and events; and (3) analyse the state-of-the-art and the progress of transatlantic science and technology cooperation. In March 2013, the EU-US Joint STI Committee Meeting determined four research areas as priorities for transatlantic cooperation: Marine & Arctic Research, NMP, Health and Transport.
EURAXESS-Links US was launched in 2007 (replacing the ERA-LINK US activity that started in 2005) and is promoting networking activities among European and US researchers.
DG Research and Innovation
Policy Officer - Research and innovation relations with USA and Canada
Unit RTD C2 – North America, Latin America and the Caribbean
Telephone: (+32) 229 95335
Dr James Gavigan
Minister-Counsellor, Research & Innovation
2175 K Street
NW Washington DC 20037, USA